Skip to content
buyModerate cluster of 2

Amit B. Shah bought $1,000 of OTLC

CFO at Oncotelic Therapeutics, Inc.. 20,000 shares at an average of $0.05, traded Jun 22, 2026, filed Jun 22, 2026.

Conviction score
41
Value
$1,000
20,000 shares
Holdings after
378,837
+6% from before
From 52-week low
+67%
low $0.03, close $0.05
From 52-week high
-55%
high $0.11, as of Jun 22, 2026

Score components

  • Role
    CFO
    +22
  • Trade size
    $1k at market
    0
  • Relative to holdings
    Holdings up 6%
    +3
  • Price context
    55% below the 52-week high
    +8
  • Cluster
    2 insiders buying within 14 days
    +8
  • Repeat buying
    First buy in 90 days
    0
  • Track record
    Too few past buys to judge (0 with prices)
    0

What happened after comparable buys

Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.

Price around the trade, and since

From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.

OTLCOct 12, 2026 · close 0.02
Since filing Jun 22, 2026: -60.0%SPY +4.8% · excess -64.8%

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™

Rows in this filing

Every transaction in Form 4 0001493152-26-029594, as filed. Open on EDGAR

DateTransactionSharesPriceValueHoldings afterFiled
Jun 22, 2026POpen-market purchase
Common Stock
+20,000$0.05$1,000378,837Jun 22, 2026

Related signals

Other insiders at Oncotelic Therapeutics, Inc. and this insider’s other filings.

ScoreCompanyInsiderValueHoldingsFiled
41Moderate
OTLCbuy 2
Oncotelic Therapeutics, Inc.
Vuong Trieu
CHAIRMAN AND CEO
$10k
240,000 shares
+0%
41Moderate
OTLCbuy 2
Oncotelic Therapeutics, Inc.
Vuong Trieu
CHAIRMAN AND CEO
$11k
255,000 shares
+0%
36Weak
OTLCbuy 2
Oncotelic Therapeutics, Inc.
Vuong Trieu
CHAIRMAN AND CEO
$15k
335,759 shares
+0%
24Weak
OTLCbuy
Oncotelic Therapeutics, Inc.
Vuong Trieu
CHAIRMAN AND CEO
$994
198,737 shares
+0%
20Weak
OTLCbuy
Oncotelic Therapeutics, Inc.
Vuong Trieu
CHAIRMAN AND CEO
$8,627
298,499 shares
+0%

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Amit B. Shah bought $1,000 of OTLC | InsiderTell